Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2004 | 09-2003 | 06-2003 | |
Sales | 1 | 7 | 0 |
Gross Profit | 1 | 7 | N/A |
Operating Income | 1 | 7 | N/A |
Pre-tax Income | 1 | 7 | 0 |
Net Income Continuous | -5 | -16 | -1 |
Net Income | $-5 | $-16 | $-1 |
EPS Basic Total Ops | 0.00 | -8,589.03 | 0.00 |
EPS Basic Continuous Ops | N/A | -8,589.03 | N/A |
EPS Diluted Total Ops | 0.00 | -8,589.03 | 0.00 |
EPS Diluted Continuous Ops | N/A | -8,589.03 | N/A |
EBITDA(a) | $1 | $7 | $N/A |